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Abstract 
Declared proficiency tests are limited in their use for testing the performance of the entire system, 
because analysts are aware that they are being tested. A blind quality control (BQC) is intended to appear 
as a real case to the analyst to remove any intentional or subconscious bias. A BQC program allows a 
real-time assessment of the laboratory’s policies and procedures and monitors reliability of casework. In 
September 2015, the Houston Forensic Science Center (HFSC) began a BQC program in blood alcohol 
analysis. Between September 2015 and July 2018, HFSC submitted 317 blind cases: 89 negative samples 
and 228 positive samples at five target concentrations (0.08, 0.15, 0.16, 0.20 and 0.25 g/100 mL; 
theoretical targets). These blood samples were analyzed by a headspace gas chromatograph interfaced 
with dual-flame ionization detectors (HS-GC-FID). All negative samples produced `no ethanol detected’ 
results. The mean (range) of reported blood alcohol concentrations (BACs) for the aforementioned target 
concentrations was 0.075 (0.073–0.078), 0.144 (0.140–0.148), 0.157 (0.155–0.160), 0.195 (0.192–0.200) 
and 0.249 (0.242–0.258) g/100 mL, respectively. The average BAC percent differences from the target for 
the positive blind cases ranged from −0.4 to −6.3%, within our uncertainty of measurement (8.95–9.18%). 
The rate of alcohol evaporation/degradation was determined negligible. A multiple linear regression 
analysis was performed to compare the % difference in BAC among five target concentrations, eight 
analysts, three HS-GC-FID instruments and two pipettes. The variables other than target concentrations 
showed no significant difference (P > 0.2). While the 0.08 g/100 mL target showed a significantly larger % 
difference than higher target concentrations (0.15–0.25 g/100 mL), the % differences among the higher 
targets were not concentration-dependent. Despite difficulties like gaining buy-in from stakeholders and 
mimicking evidence samples, the implementation of a BQC program has improved processes, shown 
methods are reliable and added confidence to staff’s testimony in court. 
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Abstract
Declared proficiency tests are limited in their use for testing the performance of the entire system,
because analysts are aware that they are being tested. A blind quality control (BQC) is intended to
appear as a real case to the analyst to remove any intentional or subconscious bias. A BQC program
allows a real-time assessment of the laboratory’s policies and procedures andmonitors reliability of
casework. In September 2015, the Houston Forensic Science Center (HFSC) began a BQC program
in blood alcohol analysis. Between September 2015 and July 2018, HFSC submitted 317 blind cases:
89 negative samples and 228 positive samples at five target concentrations (0.08, 0.15, 0.16, 0.20
and 0.25 g/100 mL; theoretical targets). These blood samples were analyzed by a headspace gas
chromatograph interfaced with dual-flame ionization detectors (HS-GC-FID). All negative samples
produced ‘no ethanol detected’ results. The mean (range) of reported blood alcohol concentrations
(BACs) for the aforementioned target concentrations was 0.075 (0.073–0.078), 0.144 (0.140–0.148),
0.157 (0.155–0.160), 0.195 (0.192–0.200) and 0.249 (0.242–0.258) g/100mL, respectively. The average
BAC percent differences from the target for the positive blind cases ranged from −0.4 to −6.3%,
within our uncertainty of measurement (8.95–9.18%). The rate of alcohol evaporation/degradation
was determined negligible. A multiple linear regression analysis was performed to compare the %
difference in BAC among five target concentrations, eight analysts, three HS-GC-FID instruments
and two pipettes. The variables other than target concentrations showed no significant difference
(P >0.2). While the 0.08 g/100 mL target showed a significantly larger % difference than higher
target concentrations (0.15–0.25 g/100 mL), the % differences among the higher targets were not
concentration-dependent. Despite difficulties like gaining buy-in from stakeholders and mimicking
evidence samples, the implementation of a BQC programhas improved processes, shownmethods
are reliable and added confidence to staff’s testimony in court.
Introduction
Accredited forensic laboratories are required to complete proficiency
tests (PT) on an annual basis. PTs, or interlaboratory testing, are
generally purchased from an accredited or approved external vendor.
Multiple laboratories across the country participate in a PT pro-
gram and analyze the same samples. The consensus results from all
participants are disseminated to the participating laboratories and
applicable accrediting bodies. These results are then evaluated by the
laboratory to determine if the PT was successfully completed. At the
Houston Forensic Science Center (HFSC), analysts are aware that
they are being assigned a PT and must analyze them as real casework
to the greatest extent possible. However, external proficiencies are
different than typical case samples in packaging, paperwork, analytes
and other subtleties. While an important part of quality assurance
programs, ‘open’ or declared PTs are limited in their use for testing
2the performance of the entire system. Declared PTs are beneficial
for the laboratory to measure results and processes against other
laboratories in the country but are typically completed once per year
per analyst for the Toxicology section as part of the accreditation
requirement. In this environment, PTs become regulatory tools rather
than educational tools designed to improve quality (1).
In their 1973 and 1975 studies, LaMotte et al. (2) found signifi-
cant differences in urine drug screening test results between declared
PTs and blind PTs. The difference in the attention given to the de-
clared PTs versus the blind PTs seemed to account for the differences
in the results. Because declared PTs have been shown to receive biased
treatment (2), laboratories are recommended to implement an inter-
nal (intralaboratory) blind quality control (BQC) program (3).While
the value of declared PTs are not negated, laboratories wanting a
more constant and unbiased way to continually improve and monitor
the performance of their processes should use an internal BQC pro-
gram. Only in this way will the analyses receive no special attention
and thus truly reflect the treatment received by actual samples (3).
To provide continuous quality improvement and real-time assess-
ment of the laboratory processes, HFSC incorporated a BQC intral-
aboratory program as a supplement to declared PT tests. In the
2009 National Academy of Sciences report, blind proficiency testing
was recommended, but not required, by the American Society of
Crime Laboratory Directors/Laboratory Accreditation Board as a
more precise test of a worker’s accuracy (4). The 2017 revision of the
General Requirements for the Competence of Testing and Calibra-
tion Laboratories standard published by the International Organiza-
tion for Standardization/International Electrotechnical Commission
(ISO/IEC 17025) requires laboratories to monitor the validity of
their results (5). To maintain compliance with the ISO/IEC 17025
standard, HFSC must meet all requirements listed in the document.
The ISO/IEC 17025 clause 7.7.1 lists out several quality controls that
a laboratory may implement to conform to this requirement. The
BQC programs fulfill both 7.7.1 j) intralaboratory comparisons and
7.7.1 k) the testing of blind samples.
The intent of the present BQC program is to continually test
the performance and adequacy of HFSC’s processes from evidence
intake to reporting. The results of this continual testing are routinely
provided to our stakeholders to help demonstrate results are accurate
and reliable. The BQC program is facilitated by HFSC’s Quality
Division, which is organizationally separate from laboratory oper-
ations reporting directly to executive management. These individuals
are intentionally detached from casework operations to maintain
objectivity for the evaluation of BQC results. Unknown quality con-
trols are prepared and introduced into the system by personnel not
connected with the actual testing. The identity of the samples must
remain unknown to the analysts throughout the entire process, and
therefore the results should be checked by a person not performing
actual testing (3).
This article presents performance of BQCs submitted to the HFSC
toxicology section for blood alcohol analysis from September 2015
to July 2018. The results of these submissions were reported from
October 2015 through August 2018.
Materials and Methods
Study design
To implement this BQC program, the quality division first reviewed
the workflow of the toxicology section. Most request types received
by the section are for driving while intoxicated (DWI) cases. The
quality division studied the analytical process for blood alcohol
analysis, from intake of evidence to reporting of the results, to ensure
BQC samples moved smoothly through the process. Next, common
blood alcohol concentrations (BACs) received were determined and
used to create samples that mimicked normal casework.
BQCs were created using two separate blood sample sets. The
first sample set, containing four different concentrations of alcohol
(ethanol), was manufactured on June 25, 2015, and submitted for
analysis as BQCs from September 3, 2015, through June 27, 2017.
The second blood sample set contained three different alcohol con-
centrations and was manufactured on April 20, 2017. This sample
set was submitted as BQCs from July 7, 2017, through July 20, 2018.
Supplemental Table I lists the sample sizes and concentrations.
HFSC established a goal of introducing 14 blind cases per month.
This represented roughly 5% of the monthly completed work. The
5% goal sought to balance introducing enough blind cases that
analysts have a real likelihood of routinely handling blind cases and
a manageable cost for the organization.
Sample preparation
HFSC purchased blood samples from Research Triangle Institute
(RTI) International. These samples were prepared in bulk by volumet-
ric addition of ethanol to whole blood fortified with 2% potassium
oxalate. RTI aliquoted ∼7 mL of the fortified blood into 10 mL grey-
top vacutainer tubes,which contained 100mg of sodium fluoride and
20 mg of potassium oxalate. The samples were analyzed in triplicate
by a reference laboratory by headspace gas chromatograph interfaced
with dual-flame ionization detector (HS-GC-FID). The first sample
set was analyzed by Clinical Reference Laboratory and the second set
was analyzed by MedTox Laboratories. The samples were shipped
on ice and maintained refrigerated at ∼4◦C after receipt by HFSC.
The quality division placed two blood tubes with fabricated case
information and paperwork into typical toxicology collection kits
used by submitting agencies.
To mimic a real toxicology case, information must include the
agency’s case number, subject name, date of birth and driver’s license
number, as well as submitting officer, collector name, incident date
and time, offense type and location. Collaboration with the Hous-
ton Police Department (HPD) allowed the quality division to gain
access to the police department’s records and evidence management
systems, which produces the agency’s incident numbers and main-
tains other case-related information. The subject’s name and date
of birth were created using Fake Name Generator (https://www.
fakenamegenerator.com/). The driver’s license consisted of a string of
eight digits resembling common Texas driver’s license numbers. The
incident date and time were dependent on the date that the samples
were submitted to the laboratory. An offense location was chosen
from within the Houston city limits using an online map to find
an actual street address. In a genuine case, the submission form is
typically filled out by both the officer and the collector.HFSCQuality
Division personnel created a handwriting distinction between these
two individuals and attempted, to the best of their ability, to disguise
their own handwriting on this form. The tubes were placed within the
toxicology collection kits, sealed with security tape, and submitted
to the HPD Property Room where submission and storage of real
evidence takes place.
Sample submission and evaluation
The submission of the kits to the property room was an imperative
step because it allowed the kit to follow the same chain of custody as
3normal cases as well as to receive the same item barcodes from the
submitting agency. These kits were brought back to HFSC by HFSC
evidence technicians and prepared for analysis in the same manner
as real cases. During analysis, the analyst was not aware if they were
working a BQC or a real case. If at any point during analysis the
analyst detected a BQC, they reported it to the CEO and the quality
division. The indicators were discussed between the analyst and the
quality division and used to improve the blind nature of the next case.
The CEO incentivized and rewarded any analyst who discovered a
BQC during analysis. This helped maintain the efficacy of the BQC
program and ensured that the cases remained blind.Once the analysis
was completed, the quality division reviewed the reported results to
determine if they were satisfactory. The BQCwas deemed satisfactory
if the reported value ± the uncertainty of measurement encompassed
the theoretical target.
Uncertainty of measurement (UM) components for HFSC alcohol
analysis included method reproducibility in % relative standard
deviation (%RSD), uncertainty of certified reference materials used
as calibrators, pipette variability in %RSD from external calibration
and duplicate analysis variability. Uncertainty was reported at a
99.73% confidence interval (k = 3). The alcohol UM value was
recalculated yearly as more quality control sample and periodic
pipette calibration data accumulated. The UM was also recalculated
after method changes (between September 2015 and May 2016,
hydrogen was used as the carrier gas instead of helium, and the
50 μL of sample with 500 μL of internal standard was used rather
than 100 and 1000 μL, respectively), and the introduction of a
new headspace system (Headspace Instrument 1 was removed and
Headspace Instrument 3 was added to service inMay 2016). The UM
values reported during the time period for this study were 9.091%
(September 2015–May 2016), 9.182% (May 2016–August 2016),
9.628% (August 2016–February 2017), 8.987% (February 2017–
February 2018) and 8.954% (February 2018-present).
Standards and reagents
Aqueous-mixed volatile standards containing ethanol, methanol, iso-
propanol and acetone at concentrations of 0.010, 0.025, 0.050,
0.100, 0.200 and 0.400 g/100 mL along with aqueous ethanol
standard at a concentration of 0.500 g/100 mL were purchased from
Cerilliant Corporation (Round Rock, TX). Aqueous low and high
ethanol standards at 0.080 and 0.400 g/100 mL, respectively, were
also purchased from Cerilliant and Lipomed (Cambridge, MA). An
aqueous low-mixed volatile standard containing ethanol, methanol,
isopropanol and acetone was prepared at 0.0192 g/100 mL by dilu-
tion of Cerilliant mixed volatile standard at 0.400 g/100 mL. Whole
blood low and high ethanol standards (∼0.08 and 0.2 g/100 mL,
respectively) and whole blood low and high mixed volatile standards
containing ethanol, methanol, isopropanol and acetone at ∼0.03–
0.08 g/100 mL and 0.08–0.15 g/100 mL, respectively, were obtained
from Cliniqa Corporation (San Marcos, CA). n-Propanol internal
standard was prepared at 0.01% v/v using n-propanol from EMD
Chemicals Inc. (Gibbstown, NJ) in deionized water obtained from
Millipore Direct-Q 3 UVwater purification system (Burlington,MA).
Blood alcohol analysis
Ethanol and other volatiles in blood were quantified using Agilent
7697A headspace sampler equipped with 7890B gas chromatograph
interfaced with dual-flame ionization detectors (HS-GC-FID). All
calibrators, controls and blood case samples were allowed to come
to room temperature and mixed by rocking prior to sampling.
Using a Hamilton Microlab 600 dual pipettor-dilutor, 100 μL of the
calibrators, controls and case samples along with 1000 μL of internal
standard were aliquoted into 20 mL HS vials. The vials were capped,
crimped and placed onto the autosampler for analysis. All case
samples were analyzed in duplicate. Samples were aliquoted in the
original order of the batch and then in reverse order of the batch. The
7-level aqueous Cerilliant standards ranged 0.010–0.500 g/100 mL
for ethanol (the six-level aqueous Cerilliant standards ranged 0.010–
0.400 g/100 mL for other volatiles) were used to generate linear
calibration curves. Two air controls (empty HS vials) were inserted
at the end of each batch sequence. After the highest calibrator, a
negative control (deionized water mixed with internal standard) was
injected, followed by a set of aqueous and whole blood controls prior
to case samples. After every 10 case samples, a whole blood ethanol
control was injected. Subsequently, another set of aqueous and whole
blood controls was injected, followed by the water control (deionized
water left open for the duration of the aliquoting process to monitor
potential environmental contamination,with internal standard added
at the end of sampling) and air controls. Four results were obtained
for each case sample: two results of the first aliquot from FID1 and
FID2 and another two results from the second aliquot from FID1 and
FID2. The average result of the first and second aliquots from FID1
was reported.
Restek RTX-BAC Plus 1 (0.32 mm × 30 m × 1.80 μm) and RTX-
BAC Plus 2 (0.32 mm × 30 × 0.60 μm) fused-silica capillary columns
were connected to FID1 and FID2, respectively, via the splitters
and restrictors. Helium was used as the carrier gas at 7 mL/min.
The GC run time was 4 min with the vial equilibration time of
7 min. The HS loop temperature was set at 70◦C and the transfer
line temperature at 90◦C. The oven temperature at 40◦C was held
for 4 min and increased to 50◦C during the post-run. The inlet
temperature was set at 110◦C using a 10:1 split ratio injection.
FID maintained the temperature at 250◦C and used hydrogen at
30 mL/min, air at 400 mL/min and nitrogen as the makeup gas at
25 mL/min. The method was validated for linearity, sensitivity, accu-
racy, precision, carryover, endogenous and exogenous interferences,
dilution integrity and autosampler stability. The limits of quantifi-
cation for all analytes (ethanol, methanol, isopropanol and acetone)
were 0.010 g/100 mL. Bias, within-run imprecision and between-run
imprecision for ethanol analysis were ≤ 5.59% difference from the
target, ≤1.54 %CV and ≤ 1.19 %CV, respectively. Further details
on instrument settings and validation study outcomes can be found
in the alcohol batch files and method validation packages posted on
the HFSC eDiscovery site (https://records.hfscdiscovery.org/).
Statistical analysis
Statistical analysis was performed using the results from the positive
samples with R version 3.5.2 (2018-12-20). Diagnostic tests per-
formed to test the fit of the linear model included: a plot of residuals
against fitted values, a Scale-Location plot of sqrt (|residuals|) against
fitted values, a Normal Q-Q plot, a plot of Cook’s distances versus
row labels, a plot of residuals against leverages and a plot of Cook’s
distances against leverage/(1-leverage). The estimation of alcohol
evaporation/degradation over time was performed using a linear
model fit of percent differences versus age of sample in days, as well
as a nonlinear model fit using local polynomial regression fitting,
using the R function loess, both of which yielded the same null result.
The linear regression was performed using the function lm in R,
and the multi-factor analysis of variance (ANOVA) was performed
4Table I. Linear Regression Model Results for the % Difference
Between Reported and Target BACs
Difference in % difference between
target and reported concentrations
Target: 0.15 g/100 mL −3.912∗∗
Target: 0.16 g/100 mL −13.017∗∗∗
Target: 0.20 g/100 mL −9.753∗∗∗
Target: 0.25 g/100 mL −8.999∗∗∗
Analyst: 2 −0.295
Analyst: 3 1.192
Analyst: 4 2.272
Analyst: 5 2.347
Analyst: 6 −2.076
Analyst: 7 −0.909
Analyst: 8 1.142
Pipette: B 0.024
Instrument 2 −1.397
Instrument 3 −2.079
Constant 24.547∗∗∗
N 228
R2 0.354
Adjusted R2 0.311
Residual Std. Error 6.960 (df = 213)
F Statistic 8.324∗∗∗ (df = 14; 213)
∗∗∗Significant at the 1 percent level.
∗∗Significant at the 5 percent level.
∗Significant at the 10 percent level.
Reference categories are as follows: target, 0.08 g/100 mL; analyst, 1; pipette, A; and
instrument, 1.
by applying the ANOVA function to the linear model object. The
regression was considered significant for P < 0.05, and the P-value
ranges were expressed using asterisks (∗) described in the caption
for Table I. The percent difference was calculated by subtracting the
expected theoretical value from the reported value, dividing by the
theoretical value and then multiplying by 100 for each point.
Results
The results from 317 BQC samples were reported between October
10, 2015, and August 10, 2018. The age of the samples ranged from
84 to 746 in days from the date of manufacture to the date of
report. The positive target concentrations included 0.08, 0.15, 0.16,
0.20 and 0.25 g/100 mL in addition to 89 negative samples. All
89 negative samples were reported as ‘no ethanol detected’ results,
and all 228 positives were reported with satisfactory results. The
ground truth for alcohol concentration for the BQC samples could
not be definitively determined. However, two target values that
approximate the ground truth were provided by the manufacturer.
The first value was the theoretical target concentration at which
the manufacturer prepared the BQC samples. The second value was
the analytical result provided by the reference laboratory. The first
value does not take into account the potential alcohol loss during the
manufacturing process. The second value does not account for the
potential differences in analytical methods and procedures between
HFSC and the reference laboratory.Table II lists themeans (ranges) of
the reported BAC for the aforementioned target concentrations and
compares % difference of the mean BQC concentrations obtained by
HFSC from the theoretical target and the analytical result obtained by
the reference laboratory at each concentration level. The% difference
in mean for BAC results betweenHFSC and the reference laboratories
were larger (−9.6 to 8.3%) than the % difference between mean
BAC results of HFSC and the theoretical targets (−6.3 to −0.4%).
This suggests the interlaboratory variability was more significant
than the variability introduced from the manufacturing process. The
theoretical target concentrations and reported concentrations are
plotted in Figure 1. The deviation from the target is visually minimal
as shown by the data points closely scattered around the slope of 1.
Effect of alcohol evaporation/degradation
Alcohol evaporation/degradation (oxidation) over time during stor-
age was evaluated to determine its effect on the reported BQC results.
The reported concentrations decreased over time, which suggested
that alcohol evaporation/degradation caused the reported concentra-
tions to be lower than the manufacturer’s target concentration. The
theoretical target concentrations were used to calculate % difference
to evaluate the effect of alcohol evaporation/degradation and to
determine the relationship via a linear regression model:
Percent differencei = β0 + β1 Age of samplei. (1)
The estimates from the model were βˆ0 = 1.66 and βˆ1 =
−8.52 x 10−5, where βˆ0 is statistically significant at the 0.05 level.
However, βˆ1, the alcohol evaporation/degradation value, was not
statistically significant. This is depicted in Figure 2, where the thin
solid line represents a simple linear regression line from Equation 1
with a virtually zero slope (−8.52 × 10–5), and the thick solid curve
is a nonlinear loess fit. Since both lines were almost horizontal (i.e.,
βˆ1 is minimal), they indicated a randomly distributed error and that
the alcohol evaporation/degradation from the BQC samples had a
negligible effect on the reported results.
Statistical model
The variables used for statistical analysis included the theoretical
target concentrations of the BQC samples, the BACs reported by
HFSC, the analyst’s identifier (1–8), pipette (A or B) and instru-
ment used (1, 2 or 3). A multiple linear regression analysis was
performed to determine what variables affected the variability of
the percent errors in measurement, i.e. the difference between the
reported concentrations from the analyst and the theoretical target
from the manufacturer, all divided by the theoretical target from the
manufacturer. The linear regression model used was
Percent differencei = β0 + β1 Target leveli + β2 Analysti
+β3 Pipettei + β4 Instrumenti + ei, (2)
where e is the error and the subscript i refers to each observation in
the given dataset and ranges from 0 to N = 228.
After fitting the models, diagnostic plots were created to
confirm that the main assumptions required to perform a linear
regression were satisfied. Results indicated normal residuals, no
extreme outliers and symmetrical error around zero (Table I and
Supplemental Table II). Supplemental Table II presents the same
model as an ANOVA.
None of the differences between analysts, pipettes or instruments
were statistically significant (P > 0.2). Each of the target concentra-
tion levels was statistically significantly different from each other. Fur-
thermore, the 0.08 g/100 mL target showed a significantly larger %
difference than higher target concentrations (0.15–0.20 g/100 mL);
however, the%differences among the higher targets were not concen-
tration dependent. In fact, 0.16 g/100 mL had the lowest differences
5Table II.Summary of BQC BACs Reported by HFSC Compared to the Theoretical Target and theMean Values from the Reference Laboratory,
which Analyzed BQC Samples in Triplicate Before Sending the Samples to HFSC
Theoretical target,
g/100 mL
Total sample
size (n)
Mean concentration
from reference
laboratory, g/100 mL
HFSC mean concentration
(range), g/100 mL
% Difference HFSC mean
from theoretical target
% Difference HFSC mean
from reference laboratory
mean
0 89 0 N/A∗ N/A∗ N/A∗
0.08 50 0.083 0.075 (0.073–0.078) −6.3 −9.6
0.15 45 0.133 0.144 (0.140–0.148) −4.0 8.3
0.16 48 0.163 0.157 (0.155–0.160) −1.9 −3.7
0.20 43 0.185 0.195 (0.192–0.200) −2.5 5.4
0.25 42 0.241 0.249 (0.242–0.258) −0.4 3.3
∗The negative samples did not contain ethanol and therefore the analysts reported them as ‘no ethanol detected’; these are shown as N/A.
Figure 1. Reported BACs from 228 BQC samples were compared to the manufacturer’s theoretical target concentrations. The solid line is the point at which the
two concentrations are equal.
Figure 2. Percent difference (between the reported BACs and the theoretical targets of 0.08, 0.15, 0.06, 0.20 and 0.25 g/100 mL) versus the age of the tested
samples. The thin solid line represents a simple linear regression line from Equation 1 with a virtually zero slope (−8.52 × 10–5) indicating randomly distributed
errors. The thick solid curve is the nonparametric loess fit, which also forms a nearly horizontal line, suggesting a minimal effect of alcohol loss over time.
(i.e., best performance), followed by the 0.20 and 0.25, then 0.15 and
then 0.08 g/100 mL target levels. This suggested that the source of the
theoretical target level variability was likely from the manufacturing
process rather than the systemic bias from the analytical method.
The alcohol loss and potential error/bias during the manufacturing
process appears to mask the possible loss during storage as the
% difference was significantly affected by the target concentration
levels but not by the age of samples. The data demonstrated that the
contributions from different analysts, instruments and pipettes to the
overall variability were not as significant as that from interlaboratory
analytical differences and the effects of manufacturing and storage
processes.
6Discussion
Benefits
Submitting BQCs into regular toxicology casework has allowed for a
continuous assessment of the case processing workflow. Fundamen-
tally, BQCs provide continual monitoring of the entire laboratory
system, not just analytical steps. Additionally, the presence of blind
samples capitalizes on the Hawthorne Effect (6). Generically, the
Hawthorne Effect is the tendency of people to alter their behavior
when they know they are being monitored. While it is difficult to
quantitate the impact on behavioral changes in analysts because of
the presence of blind control samples, minimally the results of blind
testing provide a set of data where potential analyst bias associated
with open proficiency is controlled. When blind results routinely
demonstrate low variability over time, between analysts, instruments
and calibrations, greater confidence in the routine results of unknown
samples can be inferred. Objective data can be provided to demon-
strate that the expected answer is obtained whether proficiency is
announced or is blinded. Furthermore, the BQC program provides
analysts with objective data during court testimony that demonstrates
that the procedures andmethods used to analyze evidence samples are
reliable and reproducible among all factors that could contribute to
variability of results during analysis.
Prior to submission, the blind samples are stored in a refrigerator
that is located in the BQC laboratory, only accessible by the quality
division and HFSC evidence technicians, under the temperature
conditions required by the manufacturer and HFSC policy. These
blind cases are then submitted to the HPD Property Division to mimic
a normal case submission. Since all DWI cases are automatically
requested for alcohol analysis, the BQCs return to HFSC the same
day they are submitted for analysis. Blind samples are stored at HFSC
with real evidence samples after their submission. Therefore, the
results between BQCs and real evidence samples can be compared to
determine if storage conditions, such as drastic temperature changes
related to refrigerator failures or evidence transportation from HPD
to HFSC, influenced the BAC. This comparison is not possible with
calibrators, standards and other quality control samples since they are
required to be stored separately from evidence.Notably, for the BQCs
in standard grey top tubes, refrigerated and handled as case samples,
evaporation/degradation of ethanol was not a significant effect over
746 days from manufacture. After analysis, the BQCs are returned
to the HPD property room, as typical with normal evidence. The
BQCs are later retrieved from the property room by HFSC evidence
technicians for long term storage in the BQC laboratory.
In 2016, a toxicology evidence refrigerator broke down causing
the temperature to spike outside the storage temperature range (0–
8◦C). Evidence samples were left at room temperature for ∼4 hours
while being transferred to a functioning refrigerator. Of the 529
evidence samples in this refrigerator, 16 of these were BQC samples;
5 were negative, and 11 were positive. The reported results for the 11
positive samples were consistent with results obtained from blinds
in the same sample set prior and after this incident. These blinds
performed satisfactorily and therefore demonstrated that the stability
of ethanol was not affected by the samples being at room temperature
for 4 hours prior to their analysis.
Blind samples have provided multiple opportunities for process
improvement. For instance, shortly after incorporating the BQC
program in the toxicology section, a sample tube for outsourcing
confirmatory testing broke during transit. Fortunately, this blood
tube was a BQC. This provided an opportunity to evaluate and
improve the shipment process. As a result, HFSC worked with a
vendor to create a new version of the toxicology collection kit to
prevent this from recurring.
Implementation challenges
The implementation of an intralaboratory comparison program that
is blind to laboratory personnel presented many challenges. One of
the biggest challenges was gaining buy-in from the stakeholders (e.g.,
submitting agency, district attorney’s office, staff). It was essential for
the stakeholders to understand the program and how it benefitted
them. A successful BQC program provides confidence in the reliabil-
ity of the test results and suitability of the laboratory processes.HFSC
worked closely with the HPD to form important relationships to
enable collaboration and gain buy-in for the program. Laboratories
are dependent on submitting agencies’ and requestors’ participation
for successful implementation of BQC samples.
Once buy-in from stakeholders was obtained, the next challenge
was to create samples that mimicked evidence submitted to the
laboratory. As previously mentioned, the BQCs were prepared using
the same toxicology collection kits that are used in real cases. The
blood tubes were prepared by an external vendor to look like tubes
that would be created during a blood draw for a DWI case. In
HFSC’s experience, the single most challenging factor to mimic is
handwriting on submission forms. Most cases discovered as BQCs
by the analysts have been because the handwriting was ‘too neat’.
The quality division then started to disguise the handwriting as much
as possible and even used their non-dominant hand to fill out the
submission form.
At the start of the program several kits were submitted at one
time and inevitably were assembled into the same batch for analysis
with similar case numbers. These cases were quickly discovered by
the analyst as blind cases because of the nearly consecutive case
numbers. The BQC submission schedule was revised to include a
smaller number of cases over a span of multiple days in order to
spread out the cases amongst the batches. During the study period,
less than 5% of the 317 BQCs submitted were discovered as blinds
by the analysts.
The development of a BQC program has been presented from
a practical point of view based on the needs of HFSC and the
toxicology section. Despite early critiques of such a blind quality
program being considered ‘entrapment (7)’, HFSC values the BQC
program because it provides analysts with real-time feedback about
their casework and allows HFSC to more quickly see potential
problems in casework and take preventative measures rather than
corrective actions. Toxicologists agree that seeing the results of their
BQCs gives them confidence and encourages them to improve their
procedures and internal quality control systems. HFSC encourages
other forensic laboratories to consider implementing their own BQC
program that is tailored to their specific needs.
Conclusion
Because toxicology analysis results have a direct impact on the lives
of many people, it is vital that results are accurate and reliable
on every sample tested; any false negative or positive could result
in grave consequences, including, but not limited to, revocation of
probation, imprisonment, and improper medical treatment (3). Thus,
in addition to regular PTs as required to maintain accreditation,
HFSC implemented a BQC program to assess laboratory procedures
in real time.
7Since implementing the blind program in the toxicology section
in September 2015, HFSC has yet to receive an unsatisfactory result
from a blood alcohol analysis BQC case. The results indicate no
significant variation in blood alcohol results over time, between
analyst, instrument or pipette. Therefore, we can conclude that the
methods are reliable and produce accurate results. If a practical onsite
program can be developed and put into use by other laboratories,
PTs and a BQC program will become a reliable means of evaluating
laboratories.
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